These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26259322)

  • 21. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
    Tondon R; Singh PA; Misra V; Singh M; Mohan S
    Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia.
    Jørgensen HG; Allan EK; Jiang X; Liakopoulou E; Richmond L; Eaves CJ; Eaves AC; Holyoake TL
    Leukemia; 2003 Jul; 17(7):1430-2. PubMed ID: 12835742
    [No Abstract]   [Full Text] [Related]  

  • 23. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion.
    Reid AG; Nacheva EP
    Leukemia; 2004 Jan; 18(1):178-80. PubMed ID: 14523459
    [No Abstract]   [Full Text] [Related]  

  • 24. Transition of polycythemia vera to chronic myeloid leukaemia.
    Saviola A; Fiorani C; Ferrara L; Mazzocchi V; Zucchini P; Temperani P; Longo G; Emilia G; Torelli G
    Eur J Haematol; 2005 Sep; 75(3):264-6. PubMed ID: 16104886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
    So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
    Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
    Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
    Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular composition and reticulin fibrosis in chronic myeloid leukaemia.
    Ghosh K; Varma N; Varma S; Dash S
    Indian J Cancer; 1988 Sep; 25(3):128-35. PubMed ID: 3224984
    [No Abstract]   [Full Text] [Related]  

  • 28. Extramedullary blast crisis of chronic myeloid leukaemia in a lymph node aspiration.
    Kini H; Adhikari P; Shenoy UD; Kini UA
    J Indian Med Assoc; 1996 Aug; 94(8):323. PubMed ID: 8855589
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary dermal melanoma occurring in a patient affected by Philadelphia-positive chronic myeloid leukaemia.
    Vassallo C; Muzio F; Brazzelli V; Ester O; Lazzarino M; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1300-1. PubMed ID: 17894751
    [No Abstract]   [Full Text] [Related]  

  • 30. Patterns of relapse after bone marrow transplantation for chronic myeloid leukaemia.
    Frassoni F; Sessarego M; Martinelli G; Strada P; Gualandi F; Lamparelli T; Pignatti PF; Defferrari R; Fugazza G; Bacigalupo A
    Bone Marrow Transplant; 1991; 7 Suppl 2():17-8. PubMed ID: 1878694
    [No Abstract]   [Full Text] [Related]  

  • 31. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia.
    Hariharan IK; Adams JM; Cory S
    Oncogene Res; 1988; 3(4):387-99. PubMed ID: 3147434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathological features of neuroleukemia. Changes and lessons].
    Garzuly F
    Orv Hetil; 1994 Jun; 135(24):1291-5. PubMed ID: 8015823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral hypopyon as the presenting feature of chronic myeloid leukemia.
    Sudharshan S; Kumari A; Biswas J
    Ocul Immunol Inflamm; 2008; 16(5):244-6. PubMed ID: 19065423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemia.
    Ruutu T; Peltomäki P; Volin L; Lindlöf M; Knuutila S
    Bone Marrow Transplant; 1991; 7 Suppl 2():20. PubMed ID: 1878697
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
    Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
    Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of haemoglobin-S in the pathogenesis of hyperleucocytic syndromes in Nigerian patients with chronic myeloid leukaemia.
    Ahmed SG; Ibrahim UA
    Eur J Haematol; 2007 Aug; 79(2):174-6. PubMed ID: 17573919
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment.
    Gordon MY; Goldman JM
    Br J Haematol; 1996 Oct; 95(1):10-20. PubMed ID: 8857932
    [No Abstract]   [Full Text] [Related]  

  • 38. A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemia.
    Jackson RC; Radivoyevitch T
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):765-76. PubMed ID: 25107570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myeloid leukaemia masquerading as primary myelofibrosis.
    Mohamed M; Beamish M; Grabek J
    Pathology; 2014 Jan; 46(1):75-7. PubMed ID: 24300731
    [No Abstract]   [Full Text] [Related]  

  • 40. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
    Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
    Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.